A detailed history of Met Life Investment Management, LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 17,254 shares of SERA stock, worth $137,514. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,254
Previous 7,532 129.08%
Holding current value
$137,514
Previous $44,000 204.55%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.29 - $8.43 $51,429 - $81,956
9,722 Added 129.08%
17,254 $134,000
Q2 2024

Aug 13, 2024

BUY
$5.6 - $11.69 $42,179 - $88,049
7,532 New
7,532 $44,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $236M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.